Pathogenic mitochondrial DNA point mutations
Abstract
Cell energy metabolic disorders, the basis for which is mitochondrial insufficiency caused by mitochondrial DNA (mtDNA) point mutations, give rise to a broad spectrum of clinical manifestations so the purpose of this review is to analyze the recent publications on the relationship of mtDNA point mutations to mitochondrial diseases, which unveil the importance of development of molecular diagnosis. The presence of A3243G, T3271C, T3291C, C3256T, A8344G, G8356A, A3260G, СЗЗОЗТ, and A4300Gmutations in mtDNA may suggest that there are multiorgan dysfunctions and multisystem disorders, the clinical signs and symptoms of which can vary with time, which emphasizes the importance of comprehensive genetic studies if the mitochondrial disease is assumed to be clinical.
About the Authors
N. A. LitvinovaRussian Federation
A. S. Voronkova
Russian Federation
V. S. Suchorukov
Russian Federation
References
1. Сухорукое B.C. Очерки митохондриальной патологии. М: Медпрактика-М2011; 288. (SuchorakovV.S. Mitochondrial pathology outlines. Moscow: Medpraktika2011; 288.)
2. Naviaux R.K. The Spectrum of Mitochondrial Disease in Mitochondrial and Metabolic Disorders: A Primary Care Physician's Guide. 2nd ed., 2003; http://biochemgen.ucsd. edu/mmdc/ep-3-10.pdf.
3. Pagon R.A., Adam M.P., Bird T.D. et al. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993—2014; http://www.ncbi.nlm.nih.gov/books/ NBK1224/#mtoverview.REF.chinnery.2000.188.
4. Arpa J., Cruz-Martinez A., Campos Y. et al. Prevalence and progression of mitochondrial diseases: a study of 50 patients. Muscle Nerve 2003; 28: 690-695.
5. Schaefer A.M., McFarland R., Blakely E.L. et al. Prevalence of Mitochondrial DNA Disease in Adults. Annal Neurol 2008; 63: 1: 35-39.
6. Falka M. J., Sondheimer N. Mitochondrial genetic diseases. CurrOpinPediatr2010; 22: 6: 711-716.
7. Cree L.M., Samuels B.C., Chinnerya P.F. The inheritance ofpathogenic mitochondrial DNA mutations. Biochim BiophysActa2009; 1792: 12: 1097—1102.
8. Say R.E., Whittaker R.G., Tumbull H.E. et al. Mitochondrial disease in pregnancy: a systematic review. Obstetric Medicine: The Medicine of Pregnancy 2011; 4: 3: 90—94.
9. Yarham J. W, Blakely E.L., Alstona C.L. et al. The m.3291T>C mt-tRNALeu(UUR) mutation is definitely pathogenic and causes multisystem mitochondrial disease. J NeurolSci 2013; 325: 1-2: 165-169.
10. Сухорукое B.C. Митохондриальная патология и проблемы патогенеза психических нарушений. Журн неврол и психиат 2008; 6: 83-90. (Suchorukov VS. Mitochondrial pathology and problem of the pathogenesis of mental disorders. Zhurn nevrol i psihiat 2008; 6: 83—90.)
11. Dabke P., Rao P. Diagnostic Challenges in Mitochondrial Disease. Int J Health Rehabil Sci 2012; 1: 1: 25—31.
12. Temperley R., Richter R., Dennerlein S. et al. Hungry codons promote frameshifting in human mitochondrial ribosomes. Science 2010; 327: 5963: 301.
13. Barrell B.G., Bankier A.T., Drouin J. A different genetic code in human mitochondria. Nature 1979; 282: 5735: 189—194.
14. Christian B.E., Spremulli L.L. Mechanism of Protein Biosynthesis in Mammalian Mitochondria. Biochim Biophys Acta2012; 1819: 9-10: 1035—1054.
15. He Y, Wu J., Dressman D.C. et al. Heteroplasmic mitochondrial DNA mutations in normal and tumor cells. Nature 2010; 464: 7288: 610-614.
16. Masucci J. P., Davidson M., Koga Y. et al. In vitro analysis of mutations causing myoclonus epilepsy with ragged-red
17. fibers in the mitochondrial tRNALysgene: two genotypes produce similar phenotypes. Molecul Cellul Biol 1995; 15: 5: 2872-2881.
18. Payne B.A., Wilson I.J., Yu-Wai-Man P. et al. Universal heteroplasmy of human mitochondrial DNA. Human Molecular Genetics 2013; 22: 2: 384—390.
19. Samuels D.C, Li C, Li B. et al. Recurrent Tissue-Specific mtDNA Mutations Are Common in Humans. PLoS Genet 2013;9:ll:el003929.
20. http://www.ashg.org/
21. https://www.eshg.org/
22. http://www.hugo-international.org/
23. http://omim.org/
24. www.mitomap.org/
25. Kogelnik A.M., Lott M.T., Brown M.D. et al. MITOMAP: a human mitochondrial genome database. Nucleic Acids Res 1996; 24: 1:177-179.
26. Brandon M.C, Ruiz-Pesini E., Mishmar D. et al. MITOMASTER: A Bioinformatics Tool for the Analysis of Mitochondrial DNA Sequences. Wiley Inter Science, 2008; www.interscience.wiley.com/ DOI 10.1002/humu.20801.
27. http://www.genpat.uu.se/mtDB.
28. Parsons Т., WeimerL.,EngelstadK.etal.Autonomicsymptoms in carriers of the m.3243A>G mitochondrial DNA mutation. Arch Neurol 2010; 67: 8: 976-979.
29. Mancuso M., Orsucci D., Angelini С et al. The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? J Neurol 2013; DOI 10.1007/s00415-013-7225-3.
30. Malfatti E., Laforet P., Jar del С et al. High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation. Neurology 2013; 80: 1: 100—105.
31. Nesbitt V., Pitceathly R.D., Tumbull D.M. et al. The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation-implications for diagnosis and management. J Neurol Neurosurg Psychiat 2013; 84: 936—938.
32. Laat P., Koene S., van den Heuvel L.P. et al. Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation. J Inherit Metab Dis 2012; 35: 6: 1155-1156.
33. De Wit KM., Westeneng H.J., van Engelen B.G., Mudde A.H. MIDD evolving into MELAS. Neth J Med 2012; 70: 10: 460-462.
34. Brackmann F., Abicht A., Ahting U. et al. Classical MERRF phenotype associated with mitochondrial tRNALeu (m.3243A>G) mutation. Eur JPediat2012; 171: 5: 859—862.
35. NakamuraM., YabeJ.,SudoA.etal.MEBSF/MELASoyexsp syndrome: a double pathogenic mutation in mitochondrial tRNAgenes. J MedGenet 2010; 47: 10: 659—664.
36. Salsano E., Giovagnoli A. R., Morandi L. et al. Mitochondrial dementia: A sporadic case of progressive cognitive and behavioral decline with hearing loss due to the rare m.3291T>C MELAS mutation. J Neural Sci2011; 300: 1—2: 165—168.
37. Emmanuele V., Silvers D.S., Sotiriou E. et al. MERRF and Kearns-Sayre overlap syndrome due to the mtDNA m.3291T>C mutation. MuscleNerve2011; 44: 3: 448—451.
38. KaimingL., HuiZ., KunqianJ. etal. MERRF/MELAS overlap syndrome due to the m.3291T>C mutation. Metab Brain Dis 2013; DOI 10.1007/sll011-013-9464-5.
39. Yarham J.W., Blakely E.L., Alston C.L. et al. The m.3291T>C mt-tRNALeu(UUR) mutation is definitely pathogenic and causes multisystem mitochondrial disease. J Neurol Sci 2013; 325: 1-2: 165-169.
40. Егорова Л.А., Ежов М.В., Жиганова Г.М. и др. Возможная роль мутаций митохондриального генома при ишемиче-ской болезни сердца. Клиницист 2013; 2: 4—11. (Egorova L.A., Ezhov M.V., SHiganova G.M. et al. The possible role of mutations in the mitochondrial genome in coronary heart
41. disease. Klinitsist 2013; 2: 4—11.)
42. Николаева Е.А., Козина А.А., Леонтьева И.В. и др. Системное митохондриальное заболевание: проблема дифференциальной диагностики и лечения. Рос вестн пери-натол и педиат 2012; 4: 2: 36—43. (Nikolaeva E.A., Kozina А.А., Leont'eva I.V. et al. System mitochondrial disease: differential diagnosis and treatment problems. Ros vestn perinatol i pediat 2012; 4: 2: 36—43.)
43. Zeviani M., Gellera C, Antozzi C. et al. Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNALeu(UUR). Lancet 1991; 338: 8760: 143-147.
44. Connolly B.S., Feigenbaum A.S., Robinson B.H. et al. MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutation. Biochem Biophys Res Commun 2010; 402: 2: 443—447.
45. Silvestri G., Santorelli F. M., Shanske S. et al. A new mtDNA mutation in the tRNALeu(UUR) gene associated with maternally inherited cardiomyopathy. Human Mutation 1994; 3: 1: 37-43.
Review
For citations:
Litvinova N.A., Voronkova A.S., Suchorukov V.S. Pathogenic mitochondrial DNA point mutations. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2014;59(2):29-34. (In Russ.)